In the perspective of radioimmunotherapy (RIT) of micrometastases, we compared, in multicell spheroids (MS), the uptake and retention kinetics of '2sl-F(ab)~ F6 anti-carcinoembryonic antigen (CEA) monoclonal antibody (MAb), and the affinity enhancement system (AES) using an anti-CEA/anti-DTPAindium
Bispecific Antibody Mediated Targeting of nido -Carboranes to Human Colon Carcinoma Cells
✍ Scribed by Primus, F. James; Pak, Roger H.; Rickard-Dickson, Karen J.; Szalai, György; Bolen,, James L.; Kane, Robert R.; Hawthorne, M. Frederick
- Book ID
- 126901320
- Publisher
- American Chemical Society
- Year
- 1996
- Tongue
- English
- Weight
- 126 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1043-1802
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A bispecific MAb was derived from the fusion of a hybridoma producing MAb CD3 with a hybridoma producing MAb L-DI (which is directed against a 41-kDa glycoprotein expressed in most gastro-intestinal and pancreatic carcinomas). Bispecific antibody molecules were isolated from parental antibody molecu
We have shown previously that a bispecific antibody (BsAb) directed against both germ-cell alkaline phosphatase (GCAP) and the CD3 complex on mouse T cells could effectively eliminate GCAP-positive tumor cells in vivo using an immunocompetent mouse model. However, some GCAP-negative tumor cells were
Bispecific antibodies (bsAbs) directed to tumor-associated antigens and to receptors mediating T-cell activation, such as the TCR/CD3 complex and the co-stimulatory CD28 molecule, are capable of activating T cells at the surface of tumor cells, resulting in tumor-cell killing. Here we report the pre